» Articles » PMID: 32374776

Leptin Signaling and the Intervertebral Disc: Sex Dependent Effects of Leptin Receptor Deficiency and Western Diet on the Spine in a Type 2 Diabetes Mouse Model

Overview
Journal PLoS One
Date 2020 May 7
PMID 32374776
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes and obesity are associated with back pain in juveniles and adults and are implicated in intervertebral disc (IVD) degeneration. Hypercaloric Western diets are associated with both obesity and type 2 diabetes. The objective of this study was to determine if obesity and type 2 diabetes result in spinal pathology in a sex-specific manner using in vivo diabetic and dietary mouse models. Leptin is an appetite-regulating hormone, and its deficiency leads to polyphagia, resulting in obesity and diabetes. Leptin is also associated with IVD degeneration, and increased expression of its receptor was identified in degenerated IVDs. We used young, leptin receptor deficient (Db/Db) mice to mimic the effect of diet and diabetes on adolescents. Db/Db and Control mice were fed either Western or Control diets, and were sacrificed at 3 months of age. Db/Db mice were obese, while only female mice developed diabetes. Female Db/Db mice displayed altered IVD morphology, with increased intradiscal notochordal band area, suggesting delayed IVD cell proliferation and differentiation, rather than IVD degeneration. Motion segments from Db/Db mice exhibited increased failure risk with decreased torsional failure strength. Db/Db mice also had inferior bone quality, which was most prominent in females. We conclude that obesity and diabetes due to impaired leptin signaling contribute to pathological changes in vertebrae, as well as an immature IVD phenotype, particularly of females, suggesting a sex-dependent role of leptin in the spine.

Citing Articles

Cellular and molecular mechanisms underlying obesity in degenerative spine and joint diseases.

Xiang Q, Wu Z, Zhao Y, Tian S, Lin J, Wang L Bone Res. 2024; 12(1):71.

PMID: 39658574 PMC: 11632072. DOI: 10.1038/s41413-024-00388-8.


Secreted chemokines reveal diverse inflammatory and degenerative processes in the intervertebral disc of the STZ-HFD mouse model of Type 2 diabetes.

Gonzalez C, Vaidya R, Clayton S, Clayton S, Tang S bioRxiv. 2024; .

PMID: 39131361 PMC: 11312574. DOI: 10.1101/2024.07.31.605332.


Engineered extracellular vesicle-based gene therapy for the treatment of discogenic back pain.

Tang S, Salazar-Puerta A, Heimann M, Kuchynsky K, Rincon-Benavides M, Kordowski M Biomaterials. 2024; 308:122562.

PMID: 38583365 PMC: 11164054. DOI: 10.1016/j.biomaterials.2024.122562.


Roles of organokines in intervertebral disc homeostasis and degeneration.

He Y, Liu S, Lin H, Ding F, Shao Z, Xiong L Front Endocrinol (Lausanne). 2024; 15:1340625.

PMID: 38532900 PMC: 10963452. DOI: 10.3389/fendo.2024.1340625.


From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration.

Li S, Du J, Huang Y, Gao S, Zhao Z, Chang Z Front Immunol. 2024; 15:1355503.

PMID: 38444852 PMC: 10912372. DOI: 10.3389/fimmu.2024.1355503.


References
1.
Ho-Pham L, Chau P, Do A, Nguyen H, Nguyen T . Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Osteoporos Int. 2018; 29(9):2059-2067. DOI: 10.1007/s00198-018-4579-5. View

2.
Afghani A, Cruz M, Goran M . Impaired glucose tolerance and bone mineral content in overweight latino children with a family history of type 2 diabetes. Diabetes Care. 2005; 28(2):372-8. DOI: 10.2337/diacare.28.2.372. View

3.
. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

4.
Iwaniec U, Turner R . Influence of body weight on bone mass, architecture and turnover. J Endocrinol. 2016; 230(3):R115-30. PMC: 4980254. DOI: 10.1530/JOE-16-0089. View

5.
King A, Bowe J . Animal models for diabetes: Understanding the pathogenesis and finding new treatments. Biochem Pharmacol. 2015; 99:1-10. DOI: 10.1016/j.bcp.2015.08.108. View